Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Keros Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Keros Therapeutics, Inc.Listing on record | Buy | $5.2M | conv 51First in 12mo | SEC | |
Keros Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Keros Therapeutics, Inc.Listing on record | Buy | $174.5K | conv 46First in 12mo | SEC | |
Keros Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Keros Therapeutics, Inc.Listing on record | Buy | $153.8K | conv 46First in 12mo | SEC | |
Keros Therapeutics, Inc.Listing on record | Buy | $767.9K | conv 46First in 12mo | SEC | |
Keros Therapeutics, Inc.Listing on record | Buy | $3.2M | conv 49First in 12mo | SEC |